Device Trial Radar · NCT06262633
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer: The VIOLETTA Trial
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
Mar 15, 2024
Primary completion
Aug 31, 2029
Study completion Oct 31, 2029
Sponsor
- Lead sponsor
- Chinese University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Princess Margaret Hospital, Hong Kong; Siriraj Hospital; Universiti Putra Malaysia; Chinese General Hospital and Medical Center, Philippines
- First posted
- Feb 16, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Male only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to investigate the efficacy of Targeted Microwave Ablation (TMA) under MRI-Ultrasound fusion and organ-based tracking (OBT) navigation in localized prostate cancer (PCa) in a multi-centre trial.
Conditions
- Prostate Cancer
Interventions
Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigationDevice
Targeted microwave ablation (TMA) is a novel treatment developed for focal treatment of prostate cancer, and it is applied with precise navigation guidance under the organ-based tracking (OBT) mechanism.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The oncological control of prostate cancerTime frame: At 12 months after treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peter Ka-Fung CHIU
Shatin, Hong Kong · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.